HaemSTAR – Non-malignant Haematology Research

Sangamo and Pfizer expect to present detailed data from the Alta study at a haematology conference in the fourth quarter of 2018. Netherlands biotech . ... a pulmonary complication that can occur after a blood transfusion and the leading cause of transfusion-related fatalities. ................
................